Translational Research Cancer Center Consortium Inc

TRCCC | Collaborative Immunotherapy Research

The Translational Research Cancer Centers Consortium (TRCCC)- Collaborating to better understand the interactions between the immune system and cancer! Information sharing
831794049
EIN
Pittsburgh, PA 15218 United States
Address
trccc.org
Web
TRCCC1998
Twitter (195)
Description

Translational Research Cancer Center Consortium Inc

Overview

The Translational Research Cancer Center Consortium Inc., with an Employer Identification Number (EIN) of 831794049, is a nonprofit organization focused on advancing cancer research and treatment through translational approaches. The organization aims to improve the understanding of cancer by bridging basic scientific research with clinical applications.

Mission and Activities

The mission of the Translational Research Cancer Center Consortium Inc. is centered around facilitating the progression of cancer research, particularly in areas where there is a need for enhanced understanding and treatment. They focus on creating a collaborative environment where scientific discoveries can be swiftly translated into clinical trials and therapies, benefiting patients with various types of cancer.

Financial Operations

According to recent financial filings, the organization's revenue is primarily derived from program services, with no contributions from other sources such as investments or fundraising activities. The total assets of the organization have been reported to fluctuate over the years, reflecting the ebbs and flows of funding and operational costs typical of nonprofit research organizations.

Leadership and Governance

The leadership structure of the organization includes various roles such as President, Vice President, Treasurer, and Secretary. Notable figures have included individuals such as Michael T. Lotze and Elizabeth Repasky, who have held positions in the past.

Impact and Contributions

While specific details about the organization's research projects and clinical trials are not widely available, their focus on translational research aligns with broader efforts to improve cancer treatment outcomes by accelerating the transition from laboratory findings to clinical practices. This approach is critical in addressing the complex challenges posed by cancer and in contributing to the development of innovative therapies.

Conclusion

The Translational Research Cancer Center Consortium Inc. plays a role in the cancer research ecosystem by supporting the translation of scientific discoveries into practical applications for cancer patients. However, more detailed information about specific projects and achievements is necessary to fully assess its impact within the field.

[1] https://www.sitcancer.org/events/event-description?CalendarEventKey=5fd2b903-5719-4ec2-b284-0185972b02dc&Home=%2Fhome [2] https://trp.cancer.gov [3] https://projects.propublica.org/nonprofits/organizations/831794049 [4] https://tbcrc.org/about [5] https://tbcrc.org

More

News

Poslední diskuze

Nearby

Contact
Translational Research Cancer Center Consortium Inc logo
Translational Research Cancer Center Consortium Inc
+ Follow
4.5
Reviews
Pittsburgh
Place
About the organization

- G30 -

Translational Research Cancer Centers ConsortiumExpediting Progress in Cancer Immunotherapy Home About Us Annual Meeting Job Board Sponsors Past Meetings Donate More TRCCC 2025 Details We are excited to announce that the 2025 Annual Meeting of the Translational Research Cancer Centers Consortium TRCCC will be held on February 1921 2025 at Seven Springs Mountain Resort in Champion PA. Registration and abstract submission will be opening on November 6 2024. Register soon. Fees for registration will increase after December 18 2024.

Cancer
23 Vacancy More Detail